Plastiblends India Peer Comparison
NSE: PLASTIBLEN | BSE: 523648
₹178.38
As on 16-Oct-2026IST
Market cap
₹466 Cr
Revenue (TTM)
₹847 Cr
P/E Ratio
10.2
P/B Ratio
0.9
Div. Yield
1.7 %
| Plastiblends India | Rossari Biotech | Himadri Speciality | |
|---|---|---|---|
Market cap (₹ Cr) |
466 | 2,520 | 33,322 |
Revenue (₹ Cr) |
847 | 2,661 | 5,595 |
Net Profit (₹ Cr) |
45.93 | 150.91 | 859.32 |
Net Margin (%) |
5.35 | 5.62 | 14.81 |
RoE (%) |
9.57 | 11.15 | 17.37 |
Price to Earnings |
10.15 | 16.50 | 38.98 |
Price-To-Book |
0.91 | 1.79 | 6.49 |
Income Statement (₹ Cr)
| Plastiblends India | Rossari Biotech | Himadri Speciality | |
|---|---|---|---|
|
Operating Revenue
|
846.87 | 2,661.30 | 5,594.69 |
|
Total Income
|
858.82 | 2,684.66 | 5,801.47 |
|
Total Expenditure
|
780.09 | 2,347.58 | 4,507.47 |
|
EBITDA
|
66.79 | 313.72 | 1,087.22 |
|
Depreciation
|
14.96 | 98.85 | 79.12 |
|
EBIT
|
51.82 | 214.87 | 1,008.10 |
|
Interest
|
2.11 | 36.38 | 83.89 |
|
Other Income
|
11.95 | 23.36 | 206.78 |
|
Exceptional Items
|
0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
61.67 | 201.85 | 1,130.99 |
|
Provision for Tax
|
15.74 | 50.94 | 271.67 |
|
Profit after Tax
|
45.93 | 150.91 | 859.32 |
Liabilities (₹ Cr)
| Plastiblends India | Rossari Biotech | Himadri Speciality | |
|---|---|---|---|
|
Shareholder's Funds
|
511.10 | 1,407.60 | 5,135.22 |
|
Minority Interest
|
0.00 | 0.00 | -4.49 |
|
Non-Current Liabilities
|
32.78 | 148.97 | 326.83 |
|
Current Liabilities
|
81.73 | 802.90 | 1,461.60 |
|
Total Liabilities
|
557.76 | 2,654.57 | 6,523.10 |
Assets (₹ Cr)
| Plastiblends India | Rossari Biotech | Himadri Speciality | |
|---|---|---|---|
|
Non-Current Assets
|
265.43 | 926.58 | 3,571.56 |
|
Current Assets
|
356.98 | 1,300.67 | 3,029.24 |
|
Total Assets
|
557.76 | 2,654.57 | 6,523.10 |
|
Total Debt*
|
20.00 | 407.99 | 766.57 |
|
Net Current Assets
|
275.25 | 497.78 | 1,567.64 |
|
Contingent Liabilities
|
35.78 | -- | 34.20 |
Cashflow (₹ Cr)
| Plastiblends India | Rossari Biotech | Himadri Speciality | |
|---|---|---|---|
|
Cash From Operating Activities
|
21.33 | 65.07 | 382.01 |
|
Cash Flow from Investing Activities
|
-33.01 | -219.48 | -963.81 |
|
Cash from Financing Activities
|
-8.39 | 186.32 | 590.26 |
|
Net Cash Inflow / Outflow
|
-20.07 | 31.91 | 8.45 |
Ratios
Profitability Ratios
| Plastiblends India | Rossari Biotech | Himadri Speciality | |
|---|---|---|---|
|
ROCE (%)
|
11.37 | 14.84 | 22.42 |
|
ROE (%)
|
9.57 | 11.15 | 17.37 |
|
ROA (%)
|
7.98 | 6.79 | 13.76 |
|
EBIT Margin (%)
|
6.12 | 8.07 | 18.02 |
|
Net Margin (%)
|
5.35 | 5.62 | 14.81 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 |
Growth Ratios
| Plastiblends India | Rossari Biotech | Himadri Speciality | |
|---|---|---|---|
|
Revenue Growth (%)
|
9.17 | 19.76 | 25.31 |
|
EBIT Growth (%)
|
48.50 | 6.63 | 15.74 |
|
Net Profit Growth (%)
|
40.71 | 11.66 | 31.78 |
|
EPS Growth (%)
|
40.71 | 11.75 | 27.56 |
|
Book Value Growth (%)
|
5.03 | 12.22 | 29.40 |
Valuation Ratios
| Plastiblends India | Rossari Biotech | Himadri Speciality | |
|---|---|---|---|
|
Price / Earnings
|
10.15 | 16.50 | 38.98 |
|
Price / Book Value
|
0.91 | 1.79 | 6.49 |
|
Dividend Yield (%)
|
1.67 | 0.11 | 0.12 |
|
EV/EBITDA
|
6.58 | 8.93 | 30.56 |
|
Market Cap (₹ Cr)
|
315.54 | 2,095.14 | 22,270.68 |
Solvency Ratios
| Plastiblends India | Rossari Biotech | Himadri Speciality | |
|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.06 | 0.00 |
|
Short term debt to equity ratio
|
0.04 | 0.21 | 0.16 |
|
Current Ratio
|
4.37 | 1.62 | 2.07 |
|
Quick Ratio
|
2.13 | 1.07 | 1.52 |
|
Interest Coverage
|
30.30 | 6.55 | 14.48 |
Operating Efficiency Ratios
| Plastiblends India | Rossari Biotech | Himadri Speciality | |
|---|---|---|---|
|
Debtors to sales (%)
|
15.17 | 20.80 | 18.34 |
|
Asset Turnover
|
1.47 | 1.20 | 0.90 |
|
Receivable days
|
55.18 | 78.24 | 52.05 |
|
Inventory Days
|
67.09 | 57.59 | 52.79 |
|
Payable days
|
19.18 | 66.69 | 38.65 |
|
Cash Conversion Cycle
|
103.09 | 69.14 | 66.19 |